Canada markets closed

Viveve Medical, Inc. (VIVE)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00020.0000 (0.00%)
At close: 10:52AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.14k
Enterprise Value -23.86k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.00
Price/Book (mrq)0.00
Enterprise Value/Revenue -0.00
Enterprise Value/EBITDA 0.00

Trading Information

Stock Price History

Beta (5Y Monthly) 0.14
52-Week Change 3-99.63%
S&P500 52-Week Change 323.57%
52 Week High 30.1107
52 Week Low 30.0001
50-Day Moving Average 30.0002
200-Day Moving Average 30.0013

Share Statistics

Avg Vol (3 month) 32.95k
Avg Vol (10 day) 31.47k
Shares Outstanding 510.72M
Implied Shares Outstanding 610.72M
Float 810.72M
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short (Dec 30, 2022) 4374.24k
Short Ratio (Dec 30, 2022) 44.15
Short % of Float (Dec 30, 2022) 43.49%
Short % of Shares Outstanding (Dec 30, 2022) 43.49%
Shares Short (prior month Nov 30, 2022) 4178.07k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 02, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Dec 02, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Sept 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-276.84%

Management Effectiveness

Return on Assets (ttm)-62.13%
Return on Equity (ttm)-210.99%

Income Statement

Revenue (ttm)6.83M
Revenue Per Share (ttm)0.64
Quarterly Revenue Growth (yoy)4.20%
Gross Profit (ttm)N/A
EBITDA -20.34M
Net Income Avi to Common (ttm)-28.14M
Diluted EPS (ttm)-2.6500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.91M
Total Cash Per Share (mrq)0.55
Total Debt (mrq)6.01M
Total Debt/Equity (mrq)507.94%
Current Ratio (mrq)0.89
Book Value Per Share (mrq)0.11

Cash Flow Statement

Operating Cash Flow (ttm)-16.23M
Levered Free Cash Flow (ttm)-7.58M